Market Overview

Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

Share:
  • Dendreon (NASDAQ: DNDN) - up 19% - Reports Q4 EPS of $(0.17) vs $(0.37) Est; Revenue of $74.80M vs $73.59M Est.
  • Perion Network (NASDAQ: PERI) - up 13.5% - Reports Q4 2013 Revenue of $31.3M, 47% YoY increase. EBITDA increased 56% YoY reaching $25.5M.
  • Revanece Therapeutics (NASDAQ: RVNC) - up 3% - The IPO quiet-period expired Monday and analyst are getting bullish. Analysts at Cowen, Piper Jaffray, and BMO initiated the equivalent of Buy ratings on the stock with $55, $44, and $37 price targets respectively.
  • Array BioPharma (NASDAQ: ARRY) - up 2.5% - Issues Clinical Update on ARRY-502 at Asthma at Scientific Meeting, Reports 6.8% Improvement in FEV1 vs. Placebo.
  • Odyssey Marine Exploration (NASDAQ: OMEX) - up 8.5% - Selected for recovery of SS Central America Gold.
  • NII Holdings (NASDAQ: NIHD) - up 5% - bouncing today following a more than 50 percent decline on Friday on the heels of quarterly results.
  • Allied Nevada Gold (NYSE: ANV) - up 3% - Benefiting from Gold pop as investors seek safe haven from geopolitical risk in Ukraine. Elsewhere in the sector, Barrick Gold up ~2 percent, Newmont Mining up 3.4 percent, AngloGold up nearly 4 percent, Kinross up 2 percent, Agnico Eagle up 2.4 percent, Eldorado Gold up 3.3 percent.
  • AMCOL International (NYSE: ACO) - up 4.8% - Minerals Technologies raises bid for AMCOL to $45/share in cash.
 

Related Articles (DNDN + PERI)

View Comments and Join the Discussion!

Posted-In: News Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com